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ABSTRACT
Interstrand cross-link (ICL) is a covalent modifica-
tion of both strands of DNA, which prevents DNA
strand separation during transcription and replica-
tion. Upon photoactivation 8-methoxypsoralen
(8-MOP+UVA) alkylates both strands of DNA
duplex at the 5,6-double bond of thymidines,
generating monoadducts (MAs) and ICLs. It was
thought that bulky DNA lesions such as MAs are
eliminated only in the nucleotide excision repair
pathway. Instead, non-bulky DNA lesions are sub-
strates for DNA glycosylases and AP endonucleases
which initiate the base excision repair (BER) path-
way. Here we examined whether BER might be
involved in the removal of psoralen–DNA photoad-
ducts. The results show that in human cells DNA
glycosylase NEIL1 excises the MAs in duplex DNA,
subsequently the apurinic/apyrimidinic endonu-
clease 1, APE1, removes the 3’-phosphate residue
at single-strand break generated by NEIL1. The
apparent kinetic parameters suggest that NEIL1
excises MAs with high efficiency. Consistent with
these results HeLa cells lacking APE1 and/or NEIL1
become hypersensitive to 8-MOP+UVA exposure.
Furthermore, we demonstrate that bacterial homo-
logues of NEIL1, the Fpg and Nei proteins, also
excise MAs. New substrate specificity of the
Fpg/Nei protein family provides an alternative
repair pathway for ICLs and bulky DNA damage.
INTRODUCTION
Interstrand cross-links (ICLs) are highly lethal DNA
lesions which block DNA transcription and replication by
preventing strand separation. Due to their high cytotoxi-
city, ICL-inducing agents like mitomycin C (MMC),
cisplatin and psoralens are widely used against hyperplasic
diseases such as cancer and psoriasis. Furanocoumarins
(psoralens) are naturally occurring secondary metabolites
in plants, including many fruits and vegetables. Among
several ICL-inducing agents, psoralens require UVA-
photoactivation following DNA intercalation to chemi-
cally react with DNA. 8-methoxypsoralen (8-MOP) is a
planar, tricyclic compound which intercalates into DNA
duplex at pyrimidines, preferentially at 50-TpA sites. Upon
photoactivation, 8-MOP primarily photoalkylates DNA
by cycloaddition to the 5,6-double bond of a thymidine,
generating two types of monoadducts (MA) with either
the 40,50-double bond of the furan (MAf) or the 3,4-double
bond of the pyrone (MAp) side of the psoralen (1).
A unique property of psoralen photochemistry is that
the absorption of a second photon by the MAf leads to
formation of a pyrone side 5,6-double bond adduct with
a ﬂanking thymine in the complementary strand, thus
generating an ICL (2). Although the yield of psoralen
MAs to pyrimidine bases is 3-fold higher than that of
ICLs, the latter class of damage appears to have more
severe biological eﬀect (3).
Genetic and biochemical data indicate that elimination
of ICLs is mainly linked to DNA replication and involves
several linear repair pathways including structure-
speciﬁc endonucleases, proteins required for homologous
recombination-mediated double-strand break (DSB)
repair and error-prone translesion DNA polymerases
(4–9). The thirteen FANC proteins, mutated in the
Fanconi anaemia cancer-prone syndrome, participate in
coordination of excision repair of ICLs in order to
reconstitute the genetic material with high ﬁdelity.
However, at present, the mechanism of coordination and
biochemical activities of the FANC proteins involved
in the excision of ICLs remains poorly deﬁned. More
importantly, it was believed that bulky DNA lesions
such as thymine–psoralen adducts can be eliminated
only by the nucleotide excision repair (NER) pathway
(10). However, with the exception of XPF/ERCC1-
deﬁcient cells, cells lacking critical NER components
only show a moderate sensitivity to ICL-inducing agents
exposure which induces both MA and ICL (11). These
observations hint us at the existence of an alternative
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Non-bulky endogenous oxidative DNA lesions gener-
ated by reactive oxygen species (ROS) are substrates for
two overlapping pathways: base excision repair (BER)
and nucleotide incision repair (NIR). The BER pathway is
initiated by a DNA glycosylase cleaving the N-glycosylic
bond between the abnormal base and deoxyribose, leaving
either an abasic site or a DNA single-strand break which
in turn is repaired by an apurinic/apyrimidinic (AP)
endonuclease (12). Interestingly, it has been shown that
mammalian polynucleotide kinase (PNK) can substitute
AP endonuclease in removal of 30-blocking phosphates
produced by certain DNA glycosylases (13,14). In human
cells, four DNA glycosylases/AP lyases OGG1, NTH1,
NEIL1 and NEIL2, excise the majority of oxidized bases
(14–17). Alternatively, in the NIR pathway, the major
human AP endonuclease 1, APE1, incises oxidatively
damaged DNA in a DNA glycosylase-independent
manner (18). These two pathways can work in concert
to cleanse genomic DNA from 7,8-dihydro-8-oxoguanine
(8oxoG) residues, one of the major ROS-induced DNA
lesions (19). Previously, it was shown that antisense
APE1-RNA human cell transfectants exhibited hypersen-
sitivity to MMC, suggesting a potential involvement of
APE1 in ICLs repair (20). Furthermore, similar to FA
cells, Ape1-depleted cells were sensitive to hyperoxia.
APE1 is involved in both BER and NIR suggesting that
these pathways may be involved in repair of ICLs.
Human homologues of the Escherichia coli oxidized
base-speciﬁc DNA glycosylase endonuclease VIII (Nei)
were identiﬁed by database search of the genome and
named NEIL1, 2 and 3 (human Nei-like proteins 1, 2
and 3) (16,21). The Nei-like proteins share signiﬁcant
sequence similitude with the Fpg protein, an 8oxoG-DNA
glycosylase found in E. coli. Fpg/Nei/NEIL are structu-
rally and catalytically a distinct family of bi-functional
DNA glycosylases endowed with an AP lyase activity that
incises DNA at abasic sites by a b,d-elimination mecha-
nism and leaving single-strand break carrying a phosphate
residue at the 30 and 50-terminus (22,23). Escherichia coli
mutants deﬁcient in both DNA glycosylases, endonuclease
III (nth) and nei show spontaneous mutator phenotype
and are hypersensitive to the lethal eﬀects of oxidizing
agents (24,25). Moreover, mouse embryonic stem cell
lines deﬁcient in NEIL1 protein were twice more sensitive
than control cells to low doses of g-irradiation (26).
Indeed, NEIL1 initiates base excision repair of adenine-
derived formamidopyrimidines and 5S,6R stereoisomers
of thymine glycol (Tg) which are not excised by OGG1
and NTH1 (21,27). Recently, it has been demonstrated
that NEIL1 can excise an oxidized base located in the
proximity to single-strand break suggesting its involve-
ment in repair of clustered DNA lesions induced by
ionizing radiation (28,29). Interestingly, S phase speciﬁc
expression of NEIL1 and excision of base lesions in single-
stranded and bubble-structured DNA substrates point
to its possible involvement in replication-dependent
repair (21,30).
The purpose of this study was to search for alternative
repair pathway(s) involved in removal of ICLs and bulky
psoralen–DNA photoadducts. Using a short cross-linked
oligonucleotide duplex, we demonstrated that human
DNA glycosylase and AP endonuclease initiate alternative
repair pathway for bulky psoralen–DNA photoadducts
which sought to be substrates for the NER machinery.
The potential biological importance of these ﬁndings is
discussed.
MATERIALS AND METHODS
Reagents andoligonucleotides
Chemical reagents including 8-MOP were purchased
from Sigma-Aldrich. All oligonucleotides were purchased
from Eurogentec (Seraing, Belgium), including regular
oligonucleotides, siRNAs and those containing Uracil,
5,6-dihydrouracil (DHU), Tg and 30-terminal phosphate
(30-P). A 21-mer oligonucleotide GFP1, d(GCTCTCGTC
TGXACACCGAAG), where X is either T, U or Tg, and
complementary ones GFP2, d(GCTCTTCGGTGTACA
GACGAG) and GFP3, d(CTTCGGTGTACAGACG
AGagc) were hybridized to obtain duplexes referred to
as GFP1 2 and GFP1 3, respectively (Figure 1C). These
sequence contexts were previously used to study the repair
of psoralen-induced ICLs in human cells (31). The
following oligonucleotides were used to measure
30-phosphatase activity: 30P-Exo10, d(TGACTGCA
TAp), and complementary 30-mer d(ATGCACATCGT
CTACATGCGTATGCAGTCA). Classic AP site sub-
strate was prepared by treating uracil containing oligonu-
cleotide with E. coli Uracil-DNA glycosylase (Ung).
Oligonucleotides were either 50 or 30-end labelled and
annealed as previously described (18). Oligonucleotides
carrying 30-P residue were 50-end labelled using
30-phosphatase-free T4 polynucleotide kinase from
Roche Diagnostics GmbH (Meylan, France).
The sequences of siRNA used to decrease APE1 in cells
were previously described (32). Sequences of control
siRNA were 50 (ACUAUGUAUAGGAGUACGCTT)30
and 30 (TTUGAUACAUAUCCUCAUGCG)50. Human
FANCD2 and NEIL1 smart pool siRNAs were obtained
from Dharmacon (Perbio Science, France).
Bacterial strains and proteins
Escherichia coli strains AB 1157 (IeuB6 thr-1 (gpt-proA2)
hisG4 argE3 lacY1 gaIK2 ara-14 mtl-1 xyl-5 thi-1 tsx-33
rpsL31 supE44 rac) (WT) and its isogenic derivatives
BH20 (fpg::kan
R) and BH110 (nfo::kan
R [(xth-pncA)90
X::Tn10]) were from the laboratory stock. DNA glycosy-
lase deﬁcient E. coli strains were constructed by insertional
mutagenesis as described (33). Brieﬂy, to construct fpg nei
double mutant, the spectinomycine resistance cassette
(Spc
R) was inserted into NEI gene and transferred to
the E. coli BH20 chromosome by recombination.
Cells acquiring the selectable marker were selected and
the presence of Spc
R gene insertion was further conﬁrmed
by PCR of the genomic DNA. Single clone containing
inactivated nei::Spc
R and fpg::Kan
R genes (MS2000) was
chosen for further work. Strains AB2480 (isogenic
to AB1157 except uvrA6 recA13) and SW2-8 (isogenic
to BW35 (KL16) except nei::cam
R) were gifts from
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University, Portland, OR) and Dr S. S. Wallace
(University of Vermont, Burlington, VT), respectively.
T4 DNA ligase was purchased from Roche Diagnostics
GmbH. The puriﬁed E. coli Ung, Nfo, Fpg, Nth, AlkA
and human OGG1, ANPG and NTH1 proteins were from
laboratory stock. Human Ape1 protein was expressed and
puriﬁed from E.coli BH110 (DE3) strain to avoid cross-
contamination of bacterial AP endonucleases as described
(34). The expression vectors phNEIL1 and phNEIL2 (27),
the puriﬁed E. coli Nei protein (35) and human DNA
polymerase b (36) were generously provided by Dr Hiroshi
Ide (Hiroshima University, Japan), Dr Dmitry Zharkov
(ICBFM, Novosibirsk, Russia) and Dr Grigory Dianov
(MRC, Harwell, Oxfordshire, UK), respectively. The
full-length native NEIL1 and NEIL2 were puriﬁed as
described previously (27).
Preparation ofpsoralen mono- anddiadducts
Five microgram of plasmid DNA pUC18 or 10pmol of
32P-labelled GFP1 2 were incubated for 15min in the dark
with 0.1mM 8-MOP in 50ml of 100mM Tris-HCl, pH 7.5,
5mM EDTA and 50mM NaCl, then irradiated at 365nm
and 240kJ/m
2 at room temperature. Plasmid DNA was
puriﬁed by ethanol precipitation and the presence of ICLs
was veriﬁed by denaturing agarose gel electrophoresis.
GFP1 2 was desalted by spin-down columns ﬁlled with
water equilibrated Sephadex G-50. Cross-linked and non-
cross-linked oligonucleotides were separated by denatur-
ing 20% PAGE. The oligonucleotides were eluted from
the gel strips in 2M LiClO4 and then acetone precipitated.
To obtain MAp residue, the puriﬁed cross-linked GFP1 2
was treated with hot alkali (37).
DNA glycosylase assays
The standard reaction mixture (20ml) for DNA glycosy-
lase activity contained either 0.1mg of pUC19 or 10nM of
50-[
32P] or 30-[
32P]ddAMP-labelled GFP1 2, 25mM
HEPES-KOH, pH 7.6, 100mM KCl, 1mM EDTA,
5mM 2-mercaptoethanol and 6% glycerol, unless other-
wise stated. The assay mixture for the Fpg, Nei and
OGG1 proteins contained 25mM HEPES (pH 7.6),
100mM KCl, 2mM EDTA, 5mM 2-mercaptoethanol
and 6% glycerol. For Nfo and AlkA, the assay mixture
was 20mM HEPES-KOH, pH 7.6, 50mM KCl,
0.1mM EDTA, 0.1mg/ml BSA, 1mM DTT, for Nth
and NTH1 the same but with 1mM EDTA, for ANPG
70mM HEPES-KOH, pH 7.6, 50mM KCl, 1mM EDTA,
0.1mg/ml BSA and 5mM 2-mercaptoethanol. APE1 assay
conditions vary depending on the DNA repair pathway
studied as described (18). Assays were performed with
5–20nM of pure protein at 378C for 10min, unless other-
wise stated. Reaction with pUC18 was stopped by adding
5ml of 0.25% bromophenol blue, 50% glycerol and
10mM EDTA and the products were analysed by 0.8%
agarose gel electrophoresis (0.5  TBE). Reactions
with the oligonucleotides were stopped by adding 10ml
of 0.5% SDS and 5mM EDTA and analysed as previously
described (18). Puriﬁed reaction products were heated
at 658C for 3min and separated by electrophoresis in
denaturing 20% (w/v) polyacrylamide gels (7M Urea,
0.5  TBE). Gels were exposed to a Fuji FLA-3000
Phosphor Screen and analysed using Image Gauge V3.12
software.
For the reconstitution of the repair pathway of MAs
in vitro, 20nM of GFP1 3 with a single MAp was
incubated in the presence of 20nM NEIL1, 20nM APE1,
10nM DNA polymerase b and 2U T4 DNA ligase in
buﬀer (20ml) containing 5mCi of [a-
32P]dTTP, 20mM
HEPES-KOH, pH 7.6, 50mM KCl, 0.1mg/ml BSA,
1mM DTT, 2mM ATP and 5mM MgCl2 for 10min at
378C and then 20min at 308C. Reaction products were
analysed as described above.
Formation of enzyme–DNA covalent complexes
The OGG1, NTH1 and NEIL1 proteins (200 nM) were
incubated with 0.2pmol of 8-MOP+UVA-treated 5-[
32P]-
labelled GFP1 2a t3 7 8C for 30min in 20ml of the
standard reaction mixture but in the presence of 50mM
NaBH4 (a 2M NaBH4 stock solution in water was
prepared immediately prior to use) or 100mM NaCl as
a control. The reaction was stopped by adding 5ml
of buﬀer containing 10% SDS, 30% glycerol, 25%
2-mercaptoethanol, 0.1% bromophenol blue and
300mM Tris-HCl, pH 6.8 and heating 10min at 608C.
The reaction products were separated by 15% SDS-PAGE
and analysed as described above.
Cell culture, drugtreatment and survival assay
All strains of E. coli were grown with shaking at 378Ct o
3 10
8 cells/ml in LB medium. Cells were centrifuged and
resuspended in M9 medium at a density 5 10
8 cells/ml
before irradiation. When appropriate, 8-MOP was added
to a ﬁnal concentration of 5mM, and the suspension was
allowed to stand on ice for 10min in the dark before
irradiation. Samples were irradiated at room temperature
with HPW125 Philips lamp with a pyrex water ﬁlter. The
ﬂuence through the sample was 1mW/cm
2. All experi-
ments were carried out at least three times.
HeLa cells were routinely grown at 378Ci n5 %C O 2
in Dulbecco minimal essential medium supplemented
with 10% foetal calf serum, 2mM glutamine, 100U/ml
of penicillin and 100mg/ml of streptomycin. To decrease
the target protein level, HeLa cells were plated in 6-well
plates at the concentration of 180000 cells/well and 24h
later were transfected with 100nM of appropriate siRNA
using Oligofectamine (Invitrogen) as described (38).
Cells were seeded into 96-well plate at the concentration
of 10
4 cells/well in complete medium 72h after siRNA
transfection. ICL induction by photoactivated psoralen
was achieved by incubating cells with 10mM of 8-MOP
for 20min followed by exposure to 10kJ/m
2 UVA,
afterwards cells were cultivated at 378C in complete
medium for increasing periods of time. Cell viability was
assessed using Cell Proliferation Kit II (XTT) (Roche
Diagnostics GmbH) according to the manufacturer
instructions.
For immunoblotting cells were sonicated in Laemmli
loading buﬀer. Total proteins were quantiﬁed by Bradford
assay, and separated by SDS-PAGE, then electroblotted
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Schull). The membranes were saturated in 5% non-fat
dry milk in PBS for 1h at room temperature before
adding primary antibodies for overnight at 48C. The
following antibodies were used: NEIL1 (1:600; Abcam),
actin (1:500), APE1 (1:5000; Eurogentec, Belgium).
Binding of the primary antibodies was detected with
HRP-coupled secondary antibodies followed by enhanced
chemiluminescence detection (GE Healthcare) and visua-
lized with a GeneGnome gel documentation system
(Syngene, MD, USA).
RESULTS
Roleof thebase excision repairproteins inthe cellular
responseto DNA cross-linking agents
APE1 /  cells are sensitive to MMC, however, this cross-
linking agent generates a variety of oxidative and
non-oxidative DNA lesions and only 10% of them are
ICLs (6). Consequently, to examine the potential involve-
ment of APE1 in ICLs processing, we used exposure
to photoactivated 8-MOP that generates distinct, well-
characterized and easily detectable DNA adducts. The
sensitivity of HeLa cells with reduced expression of
APE1 and FANCD2 towards several genotoxins was
examined. In agreement with the previous observations,
HeLa cells transfected with Ape1-speciﬁc siRNA were
highly sensitive to ionizing radiation (IR) and MMC but
not to UVC treatments (data not shown). Strikingly, the
cells with decreased Ape1 level were also sensitive to
8-MOP+UVA exposure, like cells with reduced expres-
sion of FANCD2 protein, suggesting a potential involve-
ment of Ape1 in the processing of psoralen–DNA adducts
(Figure 1A).
The sensitivity of APE1-depleted HeLa cells to cross-
linking agents suggest that APE1-catalysed activities
may remove psoralen-DNA adducts and thus perform
function similar to that of the structure-speciﬁc endonu-
clease XPF-ERCC1 (8). In fact, in the NIR pathway
APE1 can incise the DNA sugar-phosphate backbone
50 next to bulky lesions such as 3,N
4-benzetheno-20-
deoxynucleotides (39), thus providing a back-up function
to NER pathway. Furthermore, in the BER pathway,
APE1 acts downstream of various DNA glycosylases to
eliminate genotoxic repair intermediates. Thus depletion
of APE1 removes the major AP and NIR endonuclease
and 30-repair diesterase activities in human cells, severely
disabling two repair pathways. The ﬁrst approach was to
study whether the puriﬁed BER proteins cleave DNA
cross-links and for this purpose 8-MOP+UVA treated
supercoiled (sc) plasmid DNA was incubated with APE1
and human DNA glycosylases NTH1, NEIL1 and OGG1.
Upon cleavage at the site of damage by a DNA repair
enzyme, the sc form is converted to an open circular (oc)
form and these two forms are identiﬁed by electrophoresis
in agarose gel (40). As shown in Figure 1B, only NEIL1
converts the sc form to oc one, indicating that it spe-
ciﬁcally recognizes and incises photoactivated psoralen-
induced DNA damage (lane 7).
Oxidative DNA glycosylase, NEIL1, excises
psoralen-thymine MAs present induplex DNA
To further examine whether NEIL1 excises MAs or ICLs
or both, the short 21-mer 50-[
32P] and 30-[
32P]-dCMP-
labelled oligonucleotide duplexes, GFP1 2, were treated
with 8-MOP+UVA and the cross-linked oligonucleotides
were separated from non-cross-linked ones by denaturing
Figure 1. Role of the BER pathway in counteracting the lethal eﬀect
of 8MOP+UVA exposure. (A) Sensitivity of siRNA-treated HeLa cells
to DNA damaging agents. HeLa cells were transfected with control,
APE1 and FA-D2 siRNAs. Seventy-two hour after transfection, cells
were exposed with 8MOP+UVA and cell viability was determined 24,
48 and 72h after treatment. The ﬁgure represents the mean of three
independent experiments. The results are expressed as the percentage
of untreated cells transfected with the control siRNA 24h after
stimulation. (B) Excision of the 8-MOP+UVA induced DNA damage
by puriﬁed DNA repair enzymes. The pUC18 plasmid DNA was
irradiated in the presence or without 8-MOP and then incubated with
APE1 in buﬀer containing 5mM MgCl2 (lanes 4 and 9) or 0.5mM
MgCl2 (lanes 5 and 10) and DNA glycosylases OGG1, NEIL1, NTH1
in buﬀer containing 1mM EDTA. Lanes 1–5, 12, UVA-irradiated
plasmid; lanes 6–11, 8-MOP+UVA treated plasmid; lane 13, lambda
DNA-Hind III digest. ‘oc’ indicates open circular plasmid and ‘sc’
supercoiled plasmid DNA.
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cleaves only non-cross-linked GFP1 2 (Figure 2A, lanes 4,
8 and 12). The 50 and 30-labelled cleavage fragments
migrating at position corresponding to an 11-mer (lanes 4
and 8) and 10-mer (lane 12), respectively, indicate excision
of a psoralen–thymine MA at the position 12 of the
21-mer oligonucleotide. Consistent with the established
mechanism of action of bi-functional DNA glycosylases/
AP lyases, NEIL1 generates a Schiﬀ base intermediate
that can be characterized by the covalent trapping of
the enzyme–substrate complex by reduction with NaBH4
(Figure 2B, lane 4) (41). To characterize the substrate
speciﬁcity of NEIL1, an oligonucleotide containing
single MAp was constructed by incubating cross-linked
GFP1 2 under hot-alkali conditions (42). As expected,
base-catalysed reversal of the cross-link yields two closely
migrating DNA fragments, the ‘faster migrating’ native
and ‘slow migrating’ MAp-containing oligonucleotides
(Figure 3A, lane 5). Appearance of an 11-mer fragment
(lane 6) upon incubation with NEIL1 was accompanied
by the loss of MAp-containing fragment indicating that
NEIL1 excises MAp residues present in duplex DNA.
Furthermore, NEIL1 cleaves GFP1 2 irradiated at 405nm
in the presence of 8-MOP suggesting that it also excises
MAfs (data not shown).
To further characterize the substrate speciﬁcities of
the NEIL1 protein, the kinetic constants for the excision
of MAp and DHU G were measured. Comparison of
the kinetic constants (Table 1) shows that MAp is
the preferred substrate for NEIL1 (KM=6.30nM,
kcat/KM=3.9min
 1mM
 1) which is recognized with
high speciﬁcity.
NEIL1-generated DNA 3’-phosphate terminiare
removed by APE1
To examine the nature of 30-termini generated by NEIL1-
catalysed excision of MAp, 50-[
32P] labelled GFP1 2
duplexes containing an AP site, MAp or Tg residues
were used. As shown in Figure 3B, when excising a Tg, AP
site and MAp NEIL1 generates 11-mer DNA fragments
migrating the same distance a result that is consistent
with b,d-elimination mechanism of action of this enzyme
(lanes 3, 5 and 9). In agreement with this observation,
DNA cleavage fragments generated by the NEIL1 and
E. coli Nei proteins (lanes 8–9) migrate faster than
products generated by NTH1 and APE1 containing
30-a,b-unsaturated aldehyde and 30-hydroxyl residues,
respectively (lanes 2 and 6). Taken together, these results
demonstrate that with all DNA substrate tested NEIL1
and Nei generate products carrying a phosphate at the
30-terminus.
The catalytic rate of human APE1 acting on
30-phosphoglycolates and 30-Ps is nearly 200-fold lower
than its AP endonuclease function (43). Recently,
Wiederhold and colleagues (13) showed that polynucleo-
tide kinase and not APE1 is primarily involved in the
NEIL1-initiated BER pathway. To examine whether 30-Ps
are removed by APE1 under reaction conditions used, we
incubated 50-[
32P] labelled 10-mer DNA fragment carrying
30-P residue with the E. coli Nfo and varying amounts
of APE1 proteins at 30 and 378C. As shown in Figure 4,
at 308C 5 nM APE1 removes more than 50% of 30-P
(lanes 3 and 7) whereas 20nM APE1 and 5 nM Nfo
eliminate all 30-P residues generating 10-mer fragment
containing 30-hydroxyl with lower mobility as compared
Figure 2. The BER pathway removes psoralen-induced monoadducts.
(A) NEIL1 is active on 8-MOP+UVA-induced MAs. 50-[
32P]
(lanes 1–4) and 30-[
32P]-dCMP-labelled GFP1 (lanes 9–12) and
50-[
32P]-labelled GFP2 (lanes 5–8) were treated with 8-MOP+UVA.
Cross-linked GFP1 2 (lanes 1, 2, 5, 6, 9 and 10) was puriﬁed from non-
cross-linked GFP1 2 (lanes 3, 4, 7, 8, 11 and 12) and incubated or not
with NEIL1. ‘a’ indicates cross-linked oligonucleotide duplex, ‘b’ non-
cross-linked oligonucleotide duplex containing single MA. (B) The AP
lyase activity of NEIL1 on GFP1 2 containing psoralen MA. Puriﬁed
non-cross-linked 50-[
32P]-labelled GFP1 2 was incubated with 200nM of
OGG1, NTH1 and NEIL1 in presence of NaBH4 at 378C for 30min
before separation of the DNA–protein covalent complex and free DNA
by 10% SDS-PAGE.
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of 1mM ATP did not aﬀect activity of enzymes.
30-Phosphatase activity of APE1 but not that of Nfo is
strongly inhibited at 378C (lanes 10–12 and 14–16).
Interestingly, APE1at higher protein concentration exhi-
bits signiﬁcant 30!50 exonuclease activity generating
9-mer DNA fragment (lanes 4 and 8). These results
show that at physiologically relevant protein concentra-
tion, APE1 exhibits eﬃcient 30-phosphatase activity.
Invitro reconstitution ofthe BER pathway
forbulkypsoralen–DNA photoadducts
As we showed above, NEIL1-catalysed excision of MA
generates a single-strand break with 30-P terminus which
has to be eliminated. Hence, we have reconstituted in vitro
the BER pathway for MAps using puriﬁed proteins
(Figure 5). Incubation of a 21-mer GFP1 3 containing a
single MAp in the presence of NEIL1, APE1, DNA
polymerase b and [a-
32P]-TTP generated a labelled 12-mer
DNA fragment (lane 4). The results indicate that APE1
removes 30-P residues generated by NEIL1 and allows
DNA polymerase b to insert one nucleotide. Addition of
DNA ligase completes the restoration of the full-length
21-mer GFP1 3 (lane 5). These data demonstrate that
8-MOP-induced MAs are processed by the short-patch
BER pathway. In agreement with biochemical data, the
siRNA-transfected cells with decreased NEIL1 level were
hypersensitive to 8-MOP+UVA exposure (Figure 6). It
should be stressed that we did not observe signiﬁcant
additive increase in the sensitivity when cells were depleted
for both APE1 and NEIL1. This result indicates that
both proteins participate to a same pathway to cope
with psoralen-induced DNA damage. These in vitro and
in vivo data imply new functions of NEIL1 and APE1
in the removal of DNA adducts generated by cross-linking
agents.
Activity of variousE. coli and human DNA repair
proteins on oligodeoxynucleotides containing MAp
To further investigate the excision of psoralen MA in
DNA, we examined whether this lesion was a substrate
for previously characterized BER enzymes from E. coli
and human. We challenged a 50-[
32P]-labelled oligonucleo-
tide duplex containing single MAp with a variety of highly
puriﬁed AP endonucleases and DNA glycosylases. Since
not all DNA glycosylases possess AP-nicking activity, the
assays were made in the presence of AP endonuclease in
order to cleave DNA duplex at the potential abasic sites
generated by the base excision. When the various E. coli
and human enzymes were tested on GFP1 2 (Figure 7A),
only incubation with Fpg, Nei and NEIL1 led to the
cleavage of the labelled oligonucleotide at the position of
the psoralen–thymine MAp. Interestingly, the excision
of MAp by the Nei-like enzymes was more eﬃcient than
that of Fpg (lanes 5 and 7 versus 4). Despite being used
in excess amount, Nfo, AlkA, Nth, OGG1, NEIL2, APE1,
ANPG and NTH1 proteins did not act on GFP1 2
(lanes 2–3, 6, 8–11 and data not shown).
Photoactivated psoralen sensitivity ofDNA
glycosylase-deficient E. coli mutants
Genetic and biochemical studies of E. coli have estab-
lished that both the RecA-dependent recombination
and the NER pathways participate in removal of
Figure 3. DNA glycosylase/AP lyase activities of NEL1 on various
DNA substrates. (A) NEIL1 excises MAp. Interstrand cross-linked
50-[
32P]-labelled GFP2 oligonucleotide was reversed by hot alkaline
treatment and then incubated with NEIL1. Lane 1, size marker 10-mer;
lane 2, 11-mer; lane 3, oligonucleotide duplex containing ICL; lane 4,
as 3 but incubated with NEIL1; lane 5, oligonucleotide containing
MAp; lane 6, as 5 but incubated with NEIL1. ‘a’ indicates cross-linked
oligonucleotide duplex, ‘b’ oligonucleotide containing single MAp, ‘c’
oligonucleotide without MAp and ‘d’ NEIL1-incision product.
(B) Nature of 30-termini of the single-strand breaks generated
by NEL1. ‘b product’ indicate 11-mer fragment carrying 30-a,b-
unsaturated aldehyde moiety, ‘OH product’ 11-mer fragment carrying
30-OH group and ‘d product’ 11-mer fragment carrying 30-P residue.
Table 1. Kinetic parameters of NEIL1 for the excision of MAp and
DHU residues present in oligonucleotide duplex
DNA substrate KM (nM) kcat (min
 1) kcat/KM
(min
 1 mM
 1)
GFP1 2 6.3 1.4 0.025 0.002 3.9
DHU G2 2  6.3 0.102 0.008 4.6
Nucleic Acids Research, 2007, Vol. 35, No. 17 5677psoralen-induced cross-links (44,45). Subsequently, it was
demonstrated that psoralen MAs are removed by
UvrABC nuclease in vitro with high eﬃciency (46). To
address the physiological relevance of the Nei and Fpg-
catalysed excision of psoralen MAs, we assessed the
sensitivity of the E. coli mutant strains to 8-MOP+UVA
exposure. As shown in Figure 7B, control E. coli uvrB
recA strain was extremely sensitive to the photoactivated
psoralen, whereas E. coli nei and fpg single and nei fpg
double mutants were not particularly sensitive to treat-
ment. These results suggest that in bacteria, the NER
system is a major pathway for removal of psoralen MAs
present in DNA.
DISCUSSION
Repair of ICLs and other complex DNA lesions in
mammalian cells is linked to replication and required
successive involvement of several distinct repair pathways
in coordinated manner. At present, the underlying
mechanism of this coordination is poorly understood.
The results obtained in this study reveal that psoralen–
thymine MAs present in duplex DNA are substrate for
human oxidative DNA glycosylase, NEIL1. Analysis of
the kinetic data demonstrates that NEIL1 can eﬃciently
backup the NER pathway to repair psoralen-induced
MAs. It has been shown that NEIL1 catalyses the
b,d-elimination at AP site after oxidized base excision,
leaving a 30-P at the resulting single-strand break (16).
Here, we demonstrated using size-markers generated by
Nei, NTH1 and APE1 that NEIL1 in fact generates 30-P
termini while removing the psoralen adduct. Based on the
fact that PNK has a much higher 30-phosphatase activity
than APE1, it has been proposed that in mammalian cells
30-P generated by NEIL1 and NEIL2 is removed by PNK
in the AP endonuclease-independent BER pathway (13).
Although, human major AP endonuclease is a weak
30-phosphatase, we demonstrated that at 20nM protein
concentration APE1 eﬃciently repairs oligonucleotide
fragment containing 30-P residue. In agreement with this
result, we have fully reconstituted in vitro the repair of
MAs using puriﬁed APE1, NEIL1, DNA polymerase b
and DNA ligase. Following NEIL1 excision APE1
removes 30-P residue and allows subsequent gap ﬁlling
and ligation. Consistent with the biochemical data, HeLa
cells lacking APE1 and/or NEIL1 become hypersensitive
to 8-MOP+UVA exposure. Thus, we added one arm
of the BER pathway to the cellular defence used to cope
with the genotoxic eﬀects of cross-linking agents. These
results demonstrate that NEIL1 is not simply a backup
DNA glycosylase for OGG1, NTH1 and NEIL2 but has
distinct substrate speciﬁcity towards a speciﬁc class of
bulky DNA adducts.
Figure 4. Electrophoretic mobility of DNA fragments generated by Nfo and APE1. 30-phosphate removal by AP endonucleases was measured under
various reaction conditions. The substrate (p-10-mer) and the products (OH-10 and OH-9-mer) are indicated.
Figure 5. NEIL1 and APE1 are indispensable for the Pol b-dependent
repair of psoralen-induced MAp. In vitro reconstitution of the repair
was performed in presence of [a-
32P]dTTP with GFP1 3 containing
single MAp (lanes 1–5). Assay was conducted with various combina-
tions of proteins. Size markers were generated by incubating
50-[
32P] and 30-[
32P]-dCMP-labelled GFP1 containing MAp with
NEIL1 (lanes 6 and 7, respectively).
5678 Nucleic Acids Research, 2007, Vol. 35, No. 17NEIL1, a 44kDa protein, was initially characterized as
a DNA glycosylase speciﬁc for oxidized, saturated and
ring-fragmented bases. Several lines of evidence argue for
a biological role of NEIL1 in counteracting oxidative
DNA damage. Oxidative stress could transiently increase
NEIL1 level in human colon carcinoma cells (47).
Analysis of human polymorphic and mutant variants of
NEIL1 revealed that their low DNA glycosylase activities
and reduced expression may be involved in the pathogen-
esis in a subset of gastric cancers and increased risk of
metabolic syndrome (48,49). Cells deﬁcient in the Werner
syndrome protein (WRN), a member of the RecQ family
of DNA helicases, are hypersensitive to psoralen induced
ICLs (50,51). Lately, it has been shown that WRN
interacts with and stimulates NEIL1 in excision of
oxidative lesions from bubble DNA substrates suggesting
that NEIL1–WRN complex participates in the same
repair pathway (52). Recently, Vartanian and colleagues
(53) generated knockout (KO) mice with a frameshift
deletion and insertion in the NEIL1 gene. The steady-state
mitochondrial DNA damage and deletions from liver
tissues of NEIL1 /  KO mice were signiﬁcantly
increased compared to wild-type controls. The mice
develop spontaneously severe obesity, dyslipidemia and
fatty liver disease, suggesting that accumulation of
spontaneous DNA damage in cells lacking NEIL1 may
lead to the diseases associated with the metabolic
syndrome. Interestingly, dietary consumption or handling
Figure 6. Sensitivity of NEIL1 and/or APE1-depleted HeLa cells to
8-MOP+UVA exposure. (A) Expression of the APE1 and NEIL1
proteins in HeLa cells after siRNA transfection. Western blot of
HeLa cells transfected with APE1-siRNA, NEIL1-siRNA or unrelated
control-siRNA. (B) Cells survival 72h after transfection. Open
symbols, control non-irradiated cells; ﬁlled symbols, cells exposed to
UVA+8-MOP. Living cells were measured by XTT assay at 24, 48 and
72h as described in Materials and Methods section. The data represent
the mean of three independent experiments.
Figure 7. Repair of psoralen-induced DNA damage in bacteria.
(A) The E. coli Fpg and Nei proteins excise pyrone-side psoralen
monoadduct. The 50-[
32P]-labelled cross-linked GFP1 2 was reversed by
hot alkaline treatment and then incubated 10min at 378C in the
presence of 10 nM Nfo, Alka+Nfo, Fpg, Nei, hOGG1, NEIL1,
NEIL2, APE1, ANPG+APE1 and Nth. ‘a’ indicates oligonucleotide
with MAp, ‘b’ oligonucleotide without MAp and ‘c’ NEIL1-incision
product. (B) Survival of E. coli mutant strains exposed to photo-
activated psoralen. AB1157 wild-type strain (ﬁlled square), MS2000
fpg nei strain (open triangle), SW2-8 nei strain (open square), BH20 fpg
strain (open diamond) and AB2480 uvrA recA strain (ﬁlled circle) as
a function of exposure to UVA in presence of 5mM 8MOP. The data
represent the mean of three independent experiments.
Nucleic Acids Research, 2007, Vol. 35, No. 17 5679of psoralen-containing plants have been shown to
cause adverse eﬀects to human health (54). In light of
a new function of NEIL1, it is tempting to speculate
that NEIL1 /  KO mice may be more sensitive to
psoralen-rich diet.
Since human DNA glycosylase can excise bulky MAp,
we investigated whether this lesion was a substrate for
previously characterized E. coli Nfo, AlkA, Nth, Fpg and
Nei and human APE1, OGG1, NTH1, NEIL2 and ANPG
proteins. The results show that in addition to NEIL1, the
bacterial Fpg and Nei proteins can also excise psoralen
MAp when present in duplex oligonucleotides. In E. coli,
psoralen MAs are good substrates for UvrABC nuclease
(46) however both NER and homologous recombination
systems are required to remove the psoralen-induced
ICLs (55). Evolutionary conservation of the new substrate
speciﬁcity in bacterial Nei-like DNA glycosylases suggests
its possible biological role. Therefore, we examined
whether in E. coli Fpg/Nei-catalysed excision of MAp
provides an alternative pathway to classic NER. Surpris-
ingly, E. coli DNA glycosylase-deﬁcient mutants, in
contrast to uvrA recA mutant, were not sensitive to
8-MOP+UVA exposure indicating that in E. coli NER
is a major pathway to remove psoralen MAs.
Three-dimensional crystal structures of the Nei–DNA
complex and free NEIL1 protein show the same overall
fold for both DNA glycosylases (35,56). Both proteins
consist of two domains connected by a linker, this module
structure giving rise to a DNA-binding cleft between
domains. Based on molecular modelling it was suggested
that Nei binds to DNA and ﬂips out damaged base in
a shallow hydrophobic pocket (35). At present, structural
information for Nei and NEIL1 complexed with DNA
duplex containing an oxidized base is not yet available.
A bulky psoralen MA presents topological constraint for
its accommodation in the active sites of Nei-like DNA
glycosylases. A 3D crystal structure of the complex of
T4 endonuclease V bound to a DNA substrate containing
a bulky cyclobutane thymine dimer showed that the
enzyme kinks the DNA helix by about 608 and ﬂips out
the opposing adenine base complementary to thymine
dimer out of the DNA base stack (57). Based on these
observations we may hypothesize that the mechanism of
lesion recognition by Nei-like enzymes is diﬀerent from
that of well-studied DNA glycosylases. To access the C10
atom, most of DNA glycosylases bent the DNA and ﬂip
out an oxidized base into a speciﬁc pocket (35,58–60),
while Nei and NEIL1 similar to T4 endonuclease V may
access it by a drastic kink of the helix and ﬂipping out of
the complementary base opposite to psoralen MA. Insight
into the structural basis for clustered and bulky DNA
damage recognition by Nei-family DNA glycosylases will
have to await further investigations.
In conclusion, although in vitro NEIL1 does not
incise DNA containing single ICL, we hypothesized
that it may participate in psoralen-induced ICLs removal
after XPF-ERCC1-mediated unhooking. Alternatively,
but not exclusively, NEIL1/APE1 action could signiﬁ-
cantly reduce ICLs formation by eliminating MAf
residues.
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